MEF2D sustains activation of effector Foxp3+ Tregs during transplant survival and anticancer immunity. Di Giorgio E, Wang L, Xiong Y, Akimova T, et al. J Clin Invest 2020;130:6242-6260.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Di Giorgio E, Wang L, Xiong Y, Akimova T, et al. MEF2D sustains activation of effector Foxp3+ Tregs during transplant survival and anticancer immunity. J Clin Invest 2020;130:6242-6260.
PMID: 32790649